# Freestyle Libre and Hospital Admissions in Type 2 Diabetes

Study · id `cardio:ct-nct04997512` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04997512](<https://clinicaltrials.gov/study/NCT04997512>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04997512

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT04997512. Randomized; no masking; primary purpose treatment. Start 2021-11-01 (anticipated); primary completion 2024-08-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT04997512, source copy `cardio:ctgov-nct04997512-2021-09-08`, retrieved 2026-10-26)
- Planned start: 2021-11-01 (anticipated) (ClinicalTrials.gov record NCT04997512, source copy `cardio:ctgov-nct04997512-2021-09-08`, retrieved 2026-10-26)
- Primary completion: 2024-08-01 (anticipated) (ClinicalTrials.gov record NCT04997512, source copy `cardio:ctgov-nct04997512-2021-09-08`, retrieved 2026-10-26)
- Completion: 2025-08-01 (anticipated) (ClinicalTrials.gov record NCT04997512, source copy `cardio:ctgov-nct04997512-2021-09-08`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04997512, source copy `cardio:ctgov-nct04997512-2021-09-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04997512-2021-09-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Freestyle Libre and Hospital Admissions in Type 2 Diabetes
- Acronym: STRATUS
- Condition: Type 2 Diabetes
- Intervention (Device): Freestyle libre
- Intervention (Other): Nurse led structured intervention - hypoglycaemia education and diabetes treatment modification modification
- Lead sponsor: University of Leeds
- Lead sponsor class: OTHER
- Collaborator: Abbott Diabetes Care
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Leeds (`cardio:org-university-of-leeds`)
- Registry lists this organization as a collaborator: Abbott Diabetes Care (`cardio:org-abbott-diabetes-care`)

## Provenance

Content hash: 693ae76dd08b9dfd6699fbc32d56b720ffc355c930de487f7c477873c9881cdc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
